Transfusion and Apheresis Science
Volume 42, Issue 2 , Pages 151-156, April 2010

Controversies in the management of fever in the neutropenic cancer patient

  • Matthew D. Seftel

      Affiliations

    • Corresponding Author InformationAddress: ON2081 CancerCare Manitoba, 675 Mcdermot Avenue, Winnipeg, Manitoba, Canada R3E0V9. Tel.: +1 204 787 3594; fax: +1 204 786 0196.

Section of Haematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract 

The febrile neutropenic episode (FNE) constitutes a medical emergency, primarily because of the attendant risks of overwhelming infection and death. Infection, particularly bacterial in nature, is the most important cause of FNE, although there are other potential causes that depend on host, disease, and therapy related factors. The spectrum of microbiological pathogens varies both temporally and geographically, rendering it difficult to provide universal recommendations for antimicrobial therapy in FNE. Nonetheless, there are unifying principles in the management of FNE that are helpful in guiding therapeutic decisions. Using a case-based approach in a patient with lymphoma, the following controversies regarding the management of FNE are discussed: the role of prophylactic anti-bacterial antimicrobials, the management of febrile patients in the out-patient setting, and the choice of initial antimicrobials.

Keywords: Fever, Neutropenia, Cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1473-0502(10)00012-1

doi:10.1016/j.transci.2010.01.011

Transfusion and Apheresis Science
Volume 42, Issue 2 , Pages 151-156, April 2010